IL-18: AtH1-inducing, proinflammatory cytokine and new member of the IL-1 family

Journal of Allergy and Clinical Immunology

Volumn 103, Issue 1 I, 1999, Pages 11-24

  Dinarello, Charles A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Cytokines; IFN ; Inflammation

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18;

ALLERGY; IMMUNE RESPONSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; BIOSYNTHESIS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; TH1 CELL;

ANIMALS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-18; MICE; TH1 CELLS;

EID: 0032607876     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(99)70518-X     Document Type: Article

References (105)

1. Parnet P, Garka KE, Bonnert TP, Dower SK, Sims JE. IL-1Rrp is a novel receptor-like molecule similar to the type I interleukin-1 receptor and its homologues T1/ST2 and IL-1R AcP. J Biol Chem 1996;271:3967-70.
2. Puren AJ, Fantuzzi G, Dinarello CA. Gene expression, synthesis and secretion of IL-1β and IL-18 are differentially regulated in human blood mononuclear cells and mouse spleen cells. Eur Cytokine Netw 1998. In press.
3. Mileno MD, Margolis NH, Clark BD, Dinarello CA, Burke JE, Gelfand JA. Coagulation of whole blood stimulates interleukin-1β gene expression: absence of gene transcripts in anticoagulated blood. J Infect Dis 1995;172:308-11.
4. Shapiro L, Dinarello CA. Cytokine expression during osmotic stress. Exp Cell Res 1997;231:354-62.
5. Tone M, Thompson SAJ, Tone Y, Fairchild PJ, Waldmann H. Regulation of IL-18 (IFNγ-inducing factor) gene expression. J Immunol 1997;159:6156-63.
6. Martin TJ, Romas E, Gillespie MT. Interleukins in the control of osteoclast differentiation. Crit Rev Eukaryot Gene Expr 1998;8:107-23.
7. Stoll S, Mueller G, Kurimoto M, Saloga J, Tanimoto T, Yamauchi H, et al. Production of IL-18 (IFNγ-inducing factor) messenger RNA and functional protein by murine keratinocytes. J Immunol 1997;159:298-302.
8. Conti B, Jeong JW, Tinti C, Son JH, Joh TH. Induction of IFNγ-inducing factor in the adrenal cortex. J Biol Chem 1997;272:2035-7.
9. Sareneva T, Matikainen S, Kurimoto M, Julkunen I. Influenza A virus-induced IFN-α/β and IL-18 synergistically enhance IFN-γ gene expression in human T cells. J Immunol 1998;160:6032-8.
10. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immuno-regulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann Rev Immunol 1995;13:251-74.
11. Hunter CA, Chizzonite R, Remington JS. IL-1β is required for IL-12 to induce the production of IFN-γ by NK cells. J Immunol 1995;155:4347-54.
12. Barbulescu K, Becker C, Schlaak JF, Schmitt E, Meyer zum Büschenfelde K-H, Neurath MF. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-γ promotor in primary CD4+ T lymphocytes. J Immunol 1998;160:3642-7.
13. Takeda K, Tsutsui H, Yoshimoto T, Adachi O, Yoshida N, Kishimoto K, et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998;8:383-90.
14. Gu Y, Kuida K, Tsutsui H, Ku G, Hsiao K, Fleming MA, et al. Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 1997;275:206-9.
15. Ghayur T, Banerjee S, Hugunin M, Butler D, Herzog L, Carter A, et al. Caspase-1 processes IFNγ-inducing factor and regulates LPS-induced IFN-γ production. Nature 1997;386:619-23.
16. Fantuzzi G, Puren AJ, Harding MW, Livingston DJ, Dinarello CA. IL-18 regulation of IFN-γ production and cell proliferation as revealed in interleukin-1β converting enzyme-deficient mice. Blood 1998;91:2118-25.
17. Novick D, Kim S-H, Fantuzzi G, Reznikov L, Dinarello CA, Rubinstein M. A circulating IL-18 binding protein: isolation and characterization [abstract]. Eur Cytokine Netw 1998. In press.
18. Munder M, Mallo M, Eichmann K, Modolell M. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med 1998;187:2103-8.
19. Ohtsuki T, Micallef MJ, Kohno K, Tanimoto T, Ikeda M, Kurimoto M. Interleukin-18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res 1997;17:3253-8.
20. Shapiro L, Puren AJ, Barton HA, Novick D, Peskind RL, Su MS-S, et al. Interleukin-18 stimulates production of human immunodeficiency virus in the U1 monocytic cell line. Proc Natl Acad Sci U S A 1998;95:12550-5.
21. Okamura H, Tsutsui H, Komatsu T, Yutsudo M, Hakura A, Tanimoto T, et al. Cloning of a new cytokine that induces interferon-γ. Nature 1995;378:88-91.
22. Gu Y, Wu J, Faucheu C, Lalanne J-L, Diu A, Livingston DL, et al. Interleukin-1β converting enzyme requires oligomerization for activity of processed forms in vivo. EMBO J 1995;14:1923-31.
23. Puren AJ, Fantuzzi G, Gu Y, Su MS-S, Dinarello CA. Interleukin-18 (IFNγ-inducing factor) induces IL-1β and IL-8 via TNFα production from non-CD14+ human blood mononuclear cells. J Clin Invest 1998;101:711-24.
24. Okamura H, Nagata K, Komatsu T, Tanimoto T, Nukata Y, Tanabe F, et al. A novel costimulatory factor for gamma interferon induction found in the livers of mice causes endotoxic shock. Infect Immun 1995;63:3966-72.
25. Ushio S, Namba M, Okura T, Hattori K, Nukada Y, Akita K, et al. Cloning of the cDNA for human IFNγ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol 1996;156:4274-9.
26. Szabo S, Dighe AS, Gubler U, Murphy KM. Regulation of the interleukin-12Rb2 subunit expression in developing T helper (Th1) and Th2 cells. J Exp Med 1997;185:817-24.
27. Robinson D, Shibuya K, Mui A, Zonin F, Murphy E, Sana T, et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-γ production and activates IRAK and NFκB. Immunity 1997;7:571-81.
28. Micallef MJ, Tanimoto T, Kohno K, Ikeda M, Kurimoto M. Inter-leukin-18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma. Cancer Res 1997;57:4557-63.
29. Kohno K, Kataoka J, Ohtsuki T, Suemoto Y, Okamoto I, Usui M, et al. IFNγ-inducing factor (IGIF) is a co-stimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. J Immunol 1997;158:1541-50.
30. Yoshimoto T, Takeda K, Tanaka T, Ohkusu K, Kashiwamura S, Okamura H, et al. IL-12 upregulates IL-18 receptor expression on T cells, Th1 cells and B cells: synergism with IL-18 for IFNγ production. J Immunol 1998;161:3400-7.
31. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr, et al. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J Exp Med 1995;181:1755-62.
32. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4- deficient mice. Nature 1996;382:174-7.
33. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR, Carson RT, et al. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells. Nature 1996;382:171-4.
34. Yoshimoto T, Okamura H, Tagawa Y-I, Iwakura Y, Nakanishi K. Interleukin-18 together with interleukin-12 inhibits IgE production by induction of interferon-γ production from activated B cells. Proc Natl Acad Sci U S A 1997;94:3948-53.
35. Lauwerys BR, Renauld JC, Houssiau FA. Inhibition of in vitro immunoglobulin production by IL-12 in murine chronic graft-vs.-host disease: synergism with IL-18. Eur J Immunol 1998;28:2017-24.
36. Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikate T, et al. Purification and characterization of the human interleukin-18 receptor. J Biol Chem 1997;272:25737-42.
37. Boraschi D, Villa L, Volpini G, Boss'u P, Censini S, Ghlara P, et al. Differential activity of interleukin 1 α and interleukin 1 β in the stimulation of the immune response in vivo. Eur J Immunol 1990;20:317-21.
38. Born TL, Thomassen E, Bird TA, Sims JE. Cloning of novel receptor subunit, AcPL, required for interleukin-1 8 signaling. J Biol Chem 1998;273:29445-50.
39. Greenfeder SA, Nunes P, Kwee L, Labow M, Chizzonite RA, Ju G. Molecular cloning and characterization of a second subunit of the interleukin-1 receptor complex. J Biol Chem 1995;270:13757-65.
40. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, et al. Interleukin-1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci U S A 1993;90:6155-9.
41. Kim S-H, Novick D, Fantuzzi G, Reznikov L, Dinarello CA, Rubinstein M. The interleukin-18 binding protein is a decoy receptor lacking a transmembrane domain. Eur Cytokine Netw 1998. In press.
42. Rubinstein M, Novick D, Kim S-H, Fantuzzi G, Reznikov L, Dinarello CA. A family of poxvirus-encoded homologues of the interleukin-18 binding protein. Eur Cytokine Netw 1998. In press.
43. Novick D, Engelmann H, Wallach D, Rubinstein M. Soluble cytokine receptors are present in normal human urine. J Exp Med 1989;170:1409-14.
44. Engelmann H, Novick D, Wallach D. Two tumor necrosis factor-binding proteins purified from human urine. Evidence for immunological cross-reactivity with cell surface tumor necrosis factor receptors. J Biol Chem 1990;265:1531-6.
45. Novick D, Cohen B, Rubinstein M. The human interferon α/β receptor: characterization and molecular cloning. Cell 1994;77:391-400.
46. Novick D, Engelmann H, Wallach D, Leitner O, Revel M, Rubinstein M. Purification of soluble cytokine receptors from normal human urine by ligand-affinity and immunoaffinity chromatography. J Chromatogr 1990;510:331-7.
47. Hunter CA, Timans J, Pisacane P, Menon S, Cai G, Walker W, et al. Comparison of the effects of interleukin-1α, interleukin-1β and interferon-γ inducing factor on the production of interferon-γ by natural killer. Eur J Immunol 1997;27:2787-92.
48. Croston GE, Cao Z, Goeddel DV. NFκB activation by interleukin-1 requires an IL-1 receptor-associated protein kinase activity. J Biol Chem 1995;270:16514-7.
49. Martin MU, Falk W. The interleukin-1 receptor complex and interleukin-1 signal transduction. Eur Cytokine Netw 1997;8:5-17.
50. O'Neill LAJ, Greene C. Sigan transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants. J Leukoc Biol 1998;63:650-7.
51. Wesche H, Korherr C, Kracht M, Falk W, Resch K, Martin MU. The interleukin-1 receptor accessory protein is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 1997;272:7727-31.
52. Huang J, Gao X, Li S, Cao Z. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein. Proc Natl Acad Sci U S A 1997;94:12829-32.
53. Cao Z. Signal transduction of interleukin-1. Cytokine 1998. In press.
54. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV. IRAK TRAF-6. Nature 1996;383:443-6.
55. Malinin NL, Boldin MP, Kovalenko AV, Wallach D. MAP3K-related kinase involved in NF-kB induction by TNF, CD95 and IL-1. Nature 1997;385:540-4.
56. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive IkB kinase that activates the transcription factor NF-kB. Nature 1997;388:548-54.
57. Kojima H, Takeuchi M, Ohta T, Nishida Y, Arai N, Ikeda M, et al. Interleukin-18 activates the IRAK-TRAF6 pathway in mouse EL-4 cells. Biochem Biophys Res Commun 1998;244:183-6.
58. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, et al. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 1998;9:143-50.
59. Tsuji-Takayama K, Matsumoto S, Koide K, Takeuchi M, Ikedo M, Ohta T, et al. Interleukin-18 induces activation and association of p561ck and MAPK in a murine TH1 clone. Biochem Biophys Res Commun 1997;237:126-30.
60. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
61. Matsimoto S, Tsuji-Takayama K, Aizawa Y, Koide K, Takeuchi M, Ohta T, et al. Interleukin-18 activates NFκB in murine T helper type I cells. Biochem Biophys Res Commun 1997;234:454-7.
62. Muhl H, Shapiro L, Dinarello CA. The nitric oxide synthase inhibitor L-NMMA is a potent inhibitor of IL-18 induced expression of HIV-1 in the chronically infected macrophage U1 cell [abstract], Cytokine 1997;9:947.
63. Kohka H, Yoshino T, Iwagaki H, Sakuma I, Tanimoto T, Matsuo Y, et al. Interleukin-18/interferonγ - inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells. J Leukoc Biol 1998;64:519-27.
64. Dao T, Ohashi K, Kayano T, Kurimoto M, Okamura H. Interferonγ -inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper cells. Cell Immunol 1997;173:230-5.
65. Dao T, Mehal WZ, Crispe IN. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998;161:2217-22.
66. Mühl H, Shapiro L, Dinarello CA. The nitric oxide synthase inhibitor L-NMMA is potent inhibitor of IL-18-induced expression of HIV-1 in the chronically infected macrophage U1 cell [abstract]. Cytokine 1997;9:947.
67. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994;372:739-47.
68. Shapiro L, Heidenreich KA, Meintzer MK, Dinarello CA. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc Natl Acad Sci U S A 1998;95:7422-6.
69. Kalina U, Klebba C, Kauschat D, Pape M, Hoelzer D, Ottmann OG, et al. HIV-1 replication is enhanced by pro- and eukaryotically expressed recombinant interleukin-18. Eur Cytokine Netw 1998. In press.
70. Mandrup-Poulsen T, Bendtzen K, Dinarello CA, Nerup J. Potentiation of IL-1 mediated B-cell killing by TNF. Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic β-cell cytotoxicity. J Immunol 1987;139:4077-82.
71. Punkel C, Baquerizo H, Rabinovitch A. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of IFNγ, TNF, LT and interleukin-1. Diabetes 1988;37:133-6.
72. Rothe H, Jenkins NA, Copeland NG, Kolb H. Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J Clin Invest 1997;99:469-74.
73. Tsutsui H, Nakanishi K, Matsui K, Higashino K, Okamura H, Miyazawa Y, et al. IFNγ - inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J Immunol 1996;157:3967-73.
74. Sarvetnick N. IFNγ, IGIF and IDDM. J Clin Invest 1997;99:371-2.
75. Nolan KF, Greaves DR, Waldmann H. The human interleukin 18 gene IL18 maps to 11q22.2-q22.3, closely linked to the DRD2 gene locus and distinct from mapped IDDM loci. Genomics 1998;51:161-3.
76. Rothe H, Hibiono T, Itoh Y, Kolb H, Martin S. Systemic production of interferon-γ inducing factor (IGIF) versus local IFN-γ expression involved in the development of Th1 insulitis in NOD mice. Autoimmunity 1997;10:251-6.
77. Froyen G, Billiau F Potential therapeutic use of antibodies directed towards HuIFNγ. Biotherapy 1997;10:49-57.
78. Ferber IA, Brocke S, Cariel T-E, Ridgway W, Dinisco C, Steinman L, et al. Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). J Immunol 1996;156:5-7.
79. Horwitz MS, Evans CF, McGavern DB, Rodriguez M, Oldstone MB. Primary demyelination in transgenic mice expressing interferon-γ. Nat Med 1997;3:1037-41.
80. Badovinac V, Mostarica-Stojkovic M, Dinarello CA, Stosic-Grujicic S. Interleukin-1 receptor antagonist suppresses experimental autoimmune encephalomyelitis (EAE) in rats by influencing the activation and proliferation of encephalitogenic cells. J Neuroimmunol 1998;85:87-95.
81. Jacobs CA, Baker PE, Roux ER, Picha KS, Toivola B, Waugh S, et al. Experimental autoimmune encephalomyelitis is exacerbated by IL-1α and suppressed by soluble IL-1 receptor. J Immunol 1991;146:2983-9.
82. Netea MG, Kulberg BJ, Amiot F, van der Meer JWM. Preferential production of interleukin-6 and IL-1β by murine peritoneal macrophages exposed to IL-18: no role for TNF and lymphotoxin-α. Eur Cytokine Netw 1998. In press.
83. Udagawa N, Horwood NJ, Elliot J, Mackay A, Owens J, Okamura H, et al. Interleukin-18 is produced by osteoblasts and acts via granulocyte macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoclast formation. J Exp Med 1997;185:1005-12.
84. Horwood NJ, Udagawa N, Elliott J, Grail D, Okamura H, Kurimoto M, et al. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest 1998;101:595-603.
85. Kobayashi Y, Appella E, Yamada M, Copeland TD, Oppenheim JJ, Matsushima K. Phosphorylation of intracellular precursors of human IL-1. J Immunol 1988;140:2279-87.
86. Kobayashi K, Kai M, Gidoh M, Nakata N, Endoh M, Singh RP, et al. The possible role of interleukin (IL)-12 and interferonγ - inducing factor/IL-18 in protection against experimental Mycobacterium leprae infection in mice. Clin Immunol Immunopathol 1998;88:226-31.
87. Kawakami K, Qureshi MH, Zhang T, Okamura H, Kurimoto M, Saito A. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcal neoformans by inducing IFN-γ production. J Immunol 1997;159:5528-34.
88. Van't Wout JW, van der Meer JWM, Barza M, Dinarello CA. Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1. Eur J Immunol 1988;18:1143-6.
89. Bohn E, Sing A, Zumbihl R, Bielfeldt C, Okamura H, Kurimoto M, et al. IL-18 (IFNγ - inducing factor) regulates early cytokine production in, and promotes resolution of, bacterial infection in mice. J Immunol 1998;160:299-307.
90. Mastroeni P, Clare S, Kurimoto M, Okamura H, Harrison J, Kahn S, et al. Role of IL-18 in Salmonella resistance. Infect Immun 1999. In press.
91. Mastroeni P, Harrison JA, Robinson JH, Clare S, Khan S, Maskell DJ, et al. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent salmonellae in BALB/c mice: role of γ interferon and macrophage activation. Infect Immun 1998;66:4767-76.
92. Osaki T, Peron JM, Cai Q, Okamura H, Robbins PD, Kurimoto M, et al. IFNγ - inducing factor/IL-18 administration mediates IFNγ-and IL-12-independent antitumor effects. J Immunol 1998;160:1742-9.
93. Coughlin CM, Salhany KE, Wysocka M, Aruga E, Kurzawa H, Chang AE, et al. Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 1998;101:1441-52.
94. YoshidaY, Tasaki K, Kimurai M, Takenaga K, Yamamoto H, Yamaguchi T, et al. Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cells. Anticancer Res 1998;18:333-5.
95. Taniguchi M, Nagaoka K, Kunikata T, Kayano T, Tamauchi H, Nakamura S, et al. Characterization of anti-human interleukin-18 (IL-18)/interferon inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 ELISA. J Immunol Method 1997;206:107-13.
96. Dinarello CA. Biological basis for interleukin-1 in disease. Blood 1996;87:2095-147.
97. Cookson WOCM, Moffatt ME. Asthma: An epidemic in the absence of infection? Science 1997;275:41-2.
98. Shirakawa T, Enomoto T, Shimazu S, Hopkin JM. The inverse association between tuberculin responses and atopic disorder. Science 1996;275:77.
99. Puren AJ, Fantuzzi G, Netea M, Dinarello CA. Interleukin-18 and endotoxin synergize for interferon-γ production in whole blood cultures. J Infect Dis 1998. In press.
100. Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljan Z, Emery P, et al. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998. In press.
101. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor a (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
102. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
103. Antel JP, Becher B, Owens T. Immunotherapy for multiple sclerosis: from theory to practice. Nat Med 1996;2:1074-5.
104. Reznikov L, Fantuzzi G, Tsang M, Novick D, Kim S-H, Rubinstein M, et al. Soluble IL-1RrpFc enhances but IL-18 binding protein reduces the activity of IL-18. J Interferon Cytokine Res 1999. In press.
105. Vanham G, Toossi Z, Hirsch CS, Wallis RS, Schwander SK, Rich EA, et al. Examining a paradox in the pathogenesis of human pulmonary tuberculosis: immune activation and suppression/anergy. Tuber Lung Dis 1997;78:145-58.